The clot management devices market size has grown strongly in recent years. It will grow from $1.82 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to rising incidence of deep vein thrombosis and pulmonary embolism, increasing prevalence of cardiovascular diseases, growth in interventional radiology procedures, expanding hospital vascular care capabilities, improved awareness of clot-related complications.
The clot management devices market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to aging population with higher thrombotic risk, rising demand for minimally invasive vascular interventions, increasing focus on early diagnosis and treatment of clotting disorders, expansion of advanced stroke and thrombosis centers, growing adoption of endovascular treatment approaches. Major trends in the forecast period include rising adoption of minimally invasive clot removal procedures, increasing use of mechanical and aspiration thrombectomy devices, growing focus on rapid intervention for acute thrombotic events, expansion of catheter-based treatments for dvt and pe, increasing preference for retrievable inferior vena cava filters.
The projected increase in demand for hospitals is set to drive the growth of the clot management device market in the foreseeable future. Hospitals, specialized healthcare facilities catering to medical treatment, care, and services for individuals with diverse illnesses, injuries, or medical conditions, are on the rise due to several factors such as aging populations, urbanization, improved healthcare access, population growth, and medical tourism. Clot management devices play a pivotal role in the healthcare sector, serving as essential tools for treating conditions such as deep vein thrombosis, pulmonary embolism, and ischemic strokes. These devices offer patients effective and minimally invasive solutions, thereby enhancing overall treatment outcomes and ensuring patient safety. For example, data from the American Health Care Association reveals an increase in the number of hospitals in the US from 5,129 in 2022 to 6,120 in May 2024. Consequently, the growing demand for hospitals is fueling the expansion of the clot management device market.
Key players in the clot management device market are focusing on developing innovative technologies, such as computer-assisted vacuum thrombectomy (CAVT) systems, to meet the evolving needs of customers. Computer-assisted vacuum thrombectomy (CAVT) systems are medical devices utilized in treating blood clots, particularly in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). For instance, in April 2024, Penumbra Inc., a US-based medical company, introduced the Lightning Flash 2.0, the latest clot aspiration and vacuum thrombectomy technology. This cutting-edge device offers rapid blood clot removal, representing a significant advancement in clot management devices. The Lightning Flash 2 integrates advanced artificial intelligence and sophisticated engineering to enhance patient outcomes in both acute and chronic care settings. Equipped with advanced imaging and suction capabilities, it enables precise and efficient clot removal to address various medical scenarios.
In December 2023, Johnson & Johnson (J&J) MedTech, a US-based healthcare company, acquired Laminar Ltd. for $400 million. This acquisition is aimed at strengthening J&J MedTech's position in the clot management devices market by incorporating Laminar’s innovative left atrial appendage (LAA) closure technology. This technology helps reduce the risk of stroke in atrial fibrillation patients who are unable to take long-term blood thinners, thereby enhancing J&J's cardiovascular product portfolio and advancing stroke prevention solutions. Laminar Inc., a US-based medical device company, specializes in developing clot management devices and heart implants to reduce stroke risk.
Major companies operating in the clot management devices market are Bayer AG, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Acandis GmbH & Co KG, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Inari Medical Inc., AngioDynamics Inc., Argon Medical Devices Inc., LeMaitre Vascular Inc., iVascular SLU, Straub Medical AG, Rapid Medical, C.R. Bard Inc., InspireMD Inc.
North America was the largest region in the clot management devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clot management devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clot management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the clot management devices market by increasing costs for imported catheters, guidewires, filters, and precision-engineered components used in thrombectomy and embolectomy devices. These cost pressures have particularly affected percutaneous thrombectomy and neurovascular embolectomy segments, with north america and asia-pacific regions experiencing higher exposure due to global supply chains. Increased tariffs have raised procurement costs for hospitals and diagnostic centers and influenced purchasing decisions. However, tariffs have also encouraged domestic manufacturing, supplier diversification, and regional production expansion, supporting long-term supply chain resilience.
The clot management devices market research report is one of a series of new reports that provides clot management devices market statistics, including clot management devices industry global market size, regional shares, competitors with a clot management devices market share, detailed clot management devices market segments, market trends and opportunities, and any further data you may need to thrive in the clot management devices industry. This clot management devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A clot management device is a medical instrument crafted to prevent, manage, or eliminate blood clots within the vascular system. These devices are instrumental in treating blood clots, particularly concerning vascular conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
The primary product categories within the clot management devices market include neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF). Neurovascular embolectomy devices are specialized tools employed to extract clots from blood vessels in the brain. Percutaneous thrombectomy devices encompass various types such as aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices, catering to end-users such as diagnostic centers and hospitals.
The clot management devices market consists of sales of catheter-directed thrombolysis systems, thrombectomy devices, and inferior vena cava (IVC) filters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The clot management devices market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to aging population with higher thrombotic risk, rising demand for minimally invasive vascular interventions, increasing focus on early diagnosis and treatment of clotting disorders, expansion of advanced stroke and thrombosis centers, growing adoption of endovascular treatment approaches. Major trends in the forecast period include rising adoption of minimally invasive clot removal procedures, increasing use of mechanical and aspiration thrombectomy devices, growing focus on rapid intervention for acute thrombotic events, expansion of catheter-based treatments for dvt and pe, increasing preference for retrievable inferior vena cava filters.
The projected increase in demand for hospitals is set to drive the growth of the clot management device market in the foreseeable future. Hospitals, specialized healthcare facilities catering to medical treatment, care, and services for individuals with diverse illnesses, injuries, or medical conditions, are on the rise due to several factors such as aging populations, urbanization, improved healthcare access, population growth, and medical tourism. Clot management devices play a pivotal role in the healthcare sector, serving as essential tools for treating conditions such as deep vein thrombosis, pulmonary embolism, and ischemic strokes. These devices offer patients effective and minimally invasive solutions, thereby enhancing overall treatment outcomes and ensuring patient safety. For example, data from the American Health Care Association reveals an increase in the number of hospitals in the US from 5,129 in 2022 to 6,120 in May 2024. Consequently, the growing demand for hospitals is fueling the expansion of the clot management device market.
Key players in the clot management device market are focusing on developing innovative technologies, such as computer-assisted vacuum thrombectomy (CAVT) systems, to meet the evolving needs of customers. Computer-assisted vacuum thrombectomy (CAVT) systems are medical devices utilized in treating blood clots, particularly in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). For instance, in April 2024, Penumbra Inc., a US-based medical company, introduced the Lightning Flash 2.0, the latest clot aspiration and vacuum thrombectomy technology. This cutting-edge device offers rapid blood clot removal, representing a significant advancement in clot management devices. The Lightning Flash 2 integrates advanced artificial intelligence and sophisticated engineering to enhance patient outcomes in both acute and chronic care settings. Equipped with advanced imaging and suction capabilities, it enables precise and efficient clot removal to address various medical scenarios.
In December 2023, Johnson & Johnson (J&J) MedTech, a US-based healthcare company, acquired Laminar Ltd. for $400 million. This acquisition is aimed at strengthening J&J MedTech's position in the clot management devices market by incorporating Laminar’s innovative left atrial appendage (LAA) closure technology. This technology helps reduce the risk of stroke in atrial fibrillation patients who are unable to take long-term blood thinners, thereby enhancing J&J's cardiovascular product portfolio and advancing stroke prevention solutions. Laminar Inc., a US-based medical device company, specializes in developing clot management devices and heart implants to reduce stroke risk.
Major companies operating in the clot management devices market are Bayer AG, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Acandis GmbH & Co KG, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Inari Medical Inc., AngioDynamics Inc., Argon Medical Devices Inc., LeMaitre Vascular Inc., iVascular SLU, Straub Medical AG, Rapid Medical, C.R. Bard Inc., InspireMD Inc.
North America was the largest region in the clot management devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clot management devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clot management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the clot management devices market by increasing costs for imported catheters, guidewires, filters, and precision-engineered components used in thrombectomy and embolectomy devices. These cost pressures have particularly affected percutaneous thrombectomy and neurovascular embolectomy segments, with north america and asia-pacific regions experiencing higher exposure due to global supply chains. Increased tariffs have raised procurement costs for hospitals and diagnostic centers and influenced purchasing decisions. However, tariffs have also encouraged domestic manufacturing, supplier diversification, and regional production expansion, supporting long-term supply chain resilience.
The clot management devices market research report is one of a series of new reports that provides clot management devices market statistics, including clot management devices industry global market size, regional shares, competitors with a clot management devices market share, detailed clot management devices market segments, market trends and opportunities, and any further data you may need to thrive in the clot management devices industry. This clot management devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A clot management device is a medical instrument crafted to prevent, manage, or eliminate blood clots within the vascular system. These devices are instrumental in treating blood clots, particularly concerning vascular conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
The primary product categories within the clot management devices market include neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF). Neurovascular embolectomy devices are specialized tools employed to extract clots from blood vessels in the brain. Percutaneous thrombectomy devices encompass various types such as aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices, catering to end-users such as diagnostic centers and hospitals.
The clot management devices market consists of sales of catheter-directed thrombolysis systems, thrombectomy devices, and inferior vena cava (IVC) filters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Clot Management Devices Market Characteristics
3. Clot Management Devices Market Supply Chain Analysis
4. Global Clot Management Devices Market Trends and Strategies
5. Clot Management Devices Market Analysis of End Use Industries
7. Global Clot Management Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Clot Management Devices Total Addressable Market (TAM) Analysis for the Market
9. Clot Management Devices Market Segmentation
10. Clot Management Devices Market Regional and Country Analysis
11. Asia-Pacific Clot Management Devices Market
12. China Clot Management Devices Market
13. India Clot Management Devices Market
14. Japan Clot Management Devices Market
15. Australia Clot Management Devices Market
16. Indonesia Clot Management Devices Market
17. South Korea Clot Management Devices Market
18. Taiwan Clot Management Devices Market
19. South East Asia Clot Management Devices Market
20. Western Europe Clot Management Devices Market
21. UK Clot Management Devices Market
22. Germany Clot Management Devices Market
23. France Clot Management Devices Market
24. Italy Clot Management Devices Market
25. Spain Clot Management Devices Market
26. Eastern Europe Clot Management Devices Market
27. Russia Clot Management Devices Market
28. North America Clot Management Devices Market
29. USA Clot Management Devices Market
30. Canada Clot Management Devices Market
31. South America Clot Management Devices Market
32. Brazil Clot Management Devices Market
33. Middle East Clot Management Devices Market
34. Africa Clot Management Devices Market
36. Clot Management Devices Market Competitive Landscape and Company Profiles
37. Clot Management Devices Market Other Major and Innovative Companies
40. Clot Management Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Clot Management Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses clot management devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for clot management devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clot management devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Neurovascular Embolectomy Devices; Embolectomy Balloon Catheters; Percutaneous Thrombectomy Devices; Catheter-Directed Thrombolysis (CDT) devices; Inferior vena cava filters (IVCF)2) By Percutaneous Thrombectomy Devices Type Outlook: Aspiration Thrombectomy Devices; Percutaneous Mechanical Thrombectomy Device
3) By End User: Diagnostic centers; Hospitals
Subsegments:
1) By Neurovascular Embolectomy Devices: Aspiration Embolectomy Devices; Mechanical Embolectomy Devices; Embolectomy Balloon Catheters2) By Embolectomy Balloon Catheters: High-Pressure Balloon Catheters; Low-Pressure Balloon Catheters
3) By Percutaneous Thrombectomy Devices: Rotational Thrombectomy Devices; Aspiration Thrombectomy Devices
4) By Catheter-Directed Thrombolysis (CDT) Devices: Infusion Catheters; Guidewires For CDT
5) By Inferior Vena Cava Filters (IVCF): Permanent IVC Filters; Retrievable IVC Filters
Companies Mentioned: Bayer AG; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; Acandis GmbH & Co KG; Cook Medical; Merit Medical Systems Inc.; Penumbra Inc.; MicroVention Inc.; Inari Medical Inc.; AngioDynamics Inc.; Argon Medical Devices Inc.; LeMaitre Vascular Inc.; iVascular SLU; Straub Medical AG; Rapid Medical; C.R. Bard Inc.; InspireMD Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Clot Management Devices market report include:- Bayer AG
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Acandis GmbH & Co KG
- Cook Medical
- Merit Medical Systems Inc.
- Penumbra Inc.
- MicroVention Inc.
- Inari Medical Inc.
- AngioDynamics Inc.
- Argon Medical Devices Inc.
- LeMaitre Vascular Inc.
- iVascular SLU
- Straub Medical AG
- Rapid Medical
- C.R. Bard Inc.
- InspireMD Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.93 Billion |
| Forecasted Market Value ( USD | $ 2.37 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
